That said, at commercial scale, recombinant production can offer a major cost advantage over chemical synthesis, which requires expensive protected amino acid building blocks and coupling reagents
SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling
This is something generally not frequently seen in other known GLP-1/GIP drugs, suggesting potential contribution of glucagon biology
Oh bummer, we're sorry this product didn't work out for you
Research peptides referenced on PeptideStack are intended for in-vitro laboratory research only and are not presented as treatments, prescriptions, or instructions for human use
The pharmacokinetic profile supported once-weekly dosing, with a mean half-life of approximately six days